Amdocs (DOX) Competitors $86.61 -0.31 (-0.36%) Closing price 04:00 PM EasternExtended Trading$86.56 -0.05 (-0.06%) As of 04:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DOX vs. CTSH, LDOS, IT, BAH, CACI, EPAM, TDC, HCKT, UIS, and FORRShould you be buying Amdocs stock or one of its competitors? The main competitors of Amdocs include Cognizant Technology Solutions (CTSH), Leidos (LDOS), Gartner (IT), Booz Allen Hamilton (BAH), CACI International (CACI), EPAM Systems (EPAM), Teradata (TDC), The Hackett Group (HCKT), Unisys (UIS), and Forrester Research (FORR). These companies are all part of the "it consulting & other services" industry. Amdocs vs. Its Competitors Cognizant Technology Solutions Leidos Gartner Booz Allen Hamilton CACI International EPAM Systems Teradata The Hackett Group Unisys Forrester Research Amdocs (NASDAQ:DOX) and Cognizant Technology Solutions (NASDAQ:CTSH) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk. Which has better valuation & earnings, DOX or CTSH? Cognizant Technology Solutions has higher revenue and earnings than Amdocs. Cognizant Technology Solutions is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmdocs$4.65B2.10$493.20M$4.9317.57Cognizant Technology Solutions$19.74B1.76$2.24B$4.9214.45 Is DOX or CTSH a better dividend stock? Amdocs pays an annual dividend of $2.10 per share and has a dividend yield of 2.4%. Cognizant Technology Solutions pays an annual dividend of $1.24 per share and has a dividend yield of 1.7%. Amdocs pays out 42.6% of its earnings in the form of a dividend. Cognizant Technology Solutions pays out 25.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Amdocs has increased its dividend for 14 consecutive years and Cognizant Technology Solutions has increased its dividend for 6 consecutive years. Amdocs is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Is DOX or CTSH more profitable? Amdocs has a net margin of 11.94% compared to Cognizant Technology Solutions' net margin of 11.89%. Amdocs' return on equity of 19.66% beat Cognizant Technology Solutions' return on equity.Company Net Margins Return on Equity Return on Assets Amdocs11.94% 19.66% 10.95% Cognizant Technology Solutions 11.89%16.77%12.34% Do insiders and institutionals have more ownership in DOX or CTSH? 92.0% of Amdocs shares are held by institutional investors. Comparatively, 92.4% of Cognizant Technology Solutions shares are held by institutional investors. 15.4% of Amdocs shares are held by insiders. Comparatively, 0.3% of Cognizant Technology Solutions shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts rate DOX or CTSH? Amdocs presently has a consensus price target of $105.33, indicating a potential upside of 21.62%. Cognizant Technology Solutions has a consensus price target of $86.31, indicating a potential upside of 21.43%. Given Amdocs' stronger consensus rating and higher probable upside, analysts clearly believe Amdocs is more favorable than Cognizant Technology Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amdocs 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Cognizant Technology Solutions 0 Sell rating(s) 12 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has more volatility and risk, DOX or CTSH? Amdocs has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Comparatively, Cognizant Technology Solutions has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500. Does the media prefer DOX or CTSH? In the previous week, Cognizant Technology Solutions had 16 more articles in the media than Amdocs. MarketBeat recorded 27 mentions for Cognizant Technology Solutions and 11 mentions for Amdocs. Cognizant Technology Solutions' average media sentiment score of 1.50 beat Amdocs' score of 1.27 indicating that Cognizant Technology Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amdocs 10 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cognizant Technology Solutions 21 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryAmdocs beats Cognizant Technology Solutions on 10 of the 19 factors compared between the two stocks. Get Amdocs News Delivered to You Automatically Sign up to receive the latest news and ratings for DOX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DOX vs. The Competition Export to ExcelMetricAmdocsIT Services IndustryComputer SectorNASDAQ ExchangeMarket Cap$9.78B$16.10B$28.98B$9.56BDividend Yield2.42%1.69%3.09%4.07%P/E Ratio17.5736.3852.6225.14Price / Sales2.1012.041,258.5387.63Price / Cash11.9723.3835.5558.50Price / Book2.764.329.206.21Net Income$493.20M$443.54M$804.70M$265.38M7 Day Performance-0.85%-0.51%-0.54%-1.12%1 Month Performance-1.61%-4.67%-2.05%-0.68%1 Year Performance1.13%9.33%24,070.14%18.92% Amdocs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DOXAmdocs4.7433 of 5 stars$86.61-0.4%$105.33+21.6%+3.2%$9.78B$4.65B17.5729,058CTSHCognizant Technology Solutions4.8222 of 5 stars$69.79-0.9%$86.56+24.0%-6.6%$34.05B$20.49B14.17336,800Positive NewsEx-DividendAnalyst ForecastLDOSLeidos4.5356 of 5 stars$180.78-0.6%$179.46-0.7%+20.0%$23.23B$16.66B17.1148,000Positive NewsITGartner4.99 of 5 stars$239.15-1.4%$369.25+54.4%-49.6%$18.41B$6.30B14.7221,044BAHBooz Allen Hamilton4.8884 of 5 stars$109.52-1.9%$134.00+22.3%-27.4%$13.49B$11.98B13.4435,800Positive NewsShort Interest ↑Analyst RevisionCACICACI International2.9633 of 5 stars$497.39-1.3%$549.69+10.5%+4.5%$10.90B$8.63B22.1825,000EPAMEPAM Systems4.7825 of 5 stars$157.76-1.9%$231.73+46.9%-16.6%$8.75B$4.73B22.4161,200Positive NewsAnalyst UpgradeTDCTeradata3.8335 of 5 stars$21.06-1.6%$26.86+27.5%-25.2%$1.99B$1.68B18.605,700Positive NewsHCKTThe Hackett Group4.365 of 5 stars$20.90-1.6%$29.67+42.0%-22.7%$574.82M$313.86M34.831,478Positive NewsUISUnisys4.5152 of 5 stars$3.90-2.4%$7.75+99.0%-27.8%$278.39M$2.01B-3.3115,900FORRForrester Research3.4653 of 5 stars$9.89-3.0%N/A-46.9%$189.99M$432.47M-2.121,571 Related Companies and Tools Related Companies Cognizant Technology Solutions Competitors Leidos Competitors Gartner Competitors Booz Allen Hamilton Competitors CACI International Competitors EPAM Systems Competitors Teradata Competitors The Hackett Group Competitors Unisys Competitors Forrester Research Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DOX) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amdocs Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Amdocs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access